Joseph M. Palumbo

CIK: 0001892610

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIVI

BIOVIE INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

BIVI
BIOVIE INC.
Aug 28, 2026
Purchase(P)
Direct
4.8K shares at avg. $2.16$10K
BIVI
BIOVIE INC.
Jan 5, 2026
Award(A)
Stock Option (right to buy)
Direct
132K shares-
BIVI
BIOVIE INC.
Dec 20, 2024
Award(A)
Stock Option (right to buy)
Direct
15.4K shares-

		Type	Shares	Price		Ownership
Aug 28, 2026	BIVI BIOVIE INC.	Purchase(P)	4,843	$2.16	$10,461	Direct
Jan 5, 2026	BIVI BIOVIE INC.	Award(A) Stock Option (right to buy)	132,000	-	-	Direct
Dec 20, 2024	BIVI BIOVIE INC.	Award(A) Stock Option (right to buy)	15,417	-	-	Direct

1-3 of 3 transactions

About Palumbo Joseph M

Palumbo Joseph M (SEC CIK 0001892610) files insider reports with the SEC as Chief Medical Officer of BIOVIE INC. (BIVI).

Signal8 holds 3 ownership filings by Palumbo Joseph M, all Form 4s, filed between Jan 7, 2025 and Aug 28, 2026. Those filings report 3 transactions, from Dec 20, 2024 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Palumbo Joseph M's filings is in CARSON CITY, NV.

Recent filings by Palumbo Joseph M

Aug 28, 2026: Open-market purchase of BIVI shares (Form 4, code P).
Jan 5, 2026: Grant or award of BIVI derivative securities (Form 4, code A).
Dec 20, 2024: Grant or award of BIVI derivative securities (Form 4, code A).

Other insiders filing for BIOVIE INC. (BIVI)

Chappell Amy Suzon, Director
KIM JOANNE WENDY, Chief Financial Officer
DO CUONG V, President & CEO
ROGICH SIGMUND, Director
Sherman Michael Edward, Director
Farag Kameel D., Director

How to read Form 4 transaction codes